iTeos to Participate in Upcoming Investor Conferences
iTeos Therapeutics (Nasdaq: ITOS) has announced its participation in two major investor conferences in December 2024. The company will attend the 7th Annual Evercore HealthCONx Conference on December 3 in Coral Gables, FL, featuring a fireside chat at 9:35 AM ET, and the Piper Sandler 36th Annual Healthcare Conference on December 4 in New York, NY, with a fireside chat scheduled for 11:30 AM ET.
Both events will include one-on-one investor meetings. The presentations will be available via live webcast on iTeos' website, with recordings accessible for approximately 30 days afterward.
iTeos Therapeutics (Nasdaq: ITOS) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel dicembre 2024. L'azienda parteciperà al 7° Annual Evercore HealthCONx Conference il 3 dicembre a Coral Gables, FL, con una chiacchierata informale alle 9:35 AM ET, e al Piper Sandler 36th Annual Healthcare Conference il 4 dicembre a New York, NY, con una chiacchierata informale programmata per le 11:30 AM ET.
Entrambi gli eventi includeranno incontri one-to-one con gli investitori. Le presentazioni saranno disponibili tramite webcast in diretta sul sito web di iTeos, con registrazioni accessibili per circa 30 giorni dopo.
iTeos Therapeutics (Nasdaq: ITOS) ha anunciado su participación en dos importantes conferencias de inversores en diciembre de 2024. La compañía asistirá a la 7ª Conferencia Anual Evercore HealthCONx el 3 de diciembre en Coral Gables, FL, con una charla informal a las 9:35 AM ET, y a la 36ª Conferencia Anual de Salud de Piper Sandler el 4 de diciembre en Nueva York, NY, con una charla informal programada para las 11:30 AM ET.
Ambos eventos incluirán reuniones individuales con inversores. Las presentaciones estarán disponibles a través de una transmisión en vivo en el sitio web de iTeos, con grabaciones accesibles durante aproximadamente 30 días después.
iTeos Therapeutics (Nasdaq: ITOS)는 2024년 12월에 두 개의 주요 투자자 컨퍼런스에 참가할 것이라고 발표했습니다. 회사는 12월 3일 플로리다주 코랄 게이블스에서 열리는 제7회 에버코어 HealthCONx 컨퍼런스에 참석하여 오전 9시 35분 ET에 진행되는 대담에 참여하고, 12월 4일 뉴욕에서 열리는 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에는 오전 11시 30분 ET로 예정된 대담에 참석할 예정입니다.
두 이벤트 모두 투자자와의 일대일 회의를 포함합니다. 프레젠테이션은 iTeos의 웹사이트를 통해 실시간 웹캐스트로 제공되며, 녹화된 내용은 약 30일 동안 접근할 수 있습니다.
iTeos Therapeutics (Nasdaq: ITOS) a annoncé sa participation à deux grandes conférences pour investisseurs en décembre 2024. L'entreprise assistera à la 7ème Conférence Annuelle Evercore HealthCONx le 3 décembre à Coral Gables, FL, avec une discussion informelle prévue à 9h35 ET, et à la 36ème Conférence Annuelle de Santé Piper Sandler le 4 décembre à New York, NY, avec une discussion informelle programmée pour 11h30 ET.
Les deux événements incluront des réunions individuelles avec des investisseurs. Les présentations seront disponibles en direct via webcast sur le site web d'iTeos, avec des enregistrements accessibles pendant environ 30 jours par la suite.
iTeos Therapeutics (Nasdaq: ITOS) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Dezember 2024 angekündigt. Das Unternehmen wird am 3. Dezember an der 7. jährlichen Evercore HealthCONx-Konferenz in Coral Gables, FL teilnehmen, mit einem informellen Gespräch um 9:35 AM ET, und an der 36. jährlichen Piper Sandler Gesundheitskonferenz am 4. Dezember in New York, NY, mit einem informellen Gespräch, das um 11:30 AM ET angesetzt ist.
Beide Veranstaltungen beinhalten persönliche Meetings mit Investoren. Die Präsentationen werden live über die Website von iTeos übertragen, die Aufzeichnungen sind etwa 30 Tage lang zugänglich.
- None.
- None.
WATERTOWN, Mass. and GOSSELIES, Belgium, Nov. 26, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that company management will participate in two upcoming conferences in December:
7Th Annual Evercore HealthCONx Conference
Format: Fireside chat and one-on-one investor meetings
Date: Tuesday, December 3, 2024
Time: 9:35 AM ET
Location: Coral Gables, FL
Piper Sandler 36th Annual Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Date: Wednesday, December 4, 2024
Time: 11:30 AM ET
Location: New York, NY
A live webcast of the conference presentation will be available on the Investors section of the company’s website at www.iteostherapeutics.com. An archived replay will be available for approximately 30 days following the presentation.
About iTeos Therapeutics, Inc.
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immunosuppressive pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
Internet Posting of Information
iTeos routinely posts information that may be important to investors in the 'Investors' section of its website at www.iteostherapeutics.com. The Company encourages investors and potential investors to consult our website regularly for important information about iTeos.
For further information, please contact:
Investor Contact:
Carl Mauch
iTeos Therapeutics, Inc.
carl.mauch@iteostherapeutics.com
Media Contact:
media@iteostherapeutics.com
FAQ
What investor conferences will iTeos (ITOS) attend in December 2024?
When is iTeos' (ITOS) presentation at the Evercore HealthCONx Conference?
How long will iTeos' (ITOS) conference webcasts be available for replay?
Where can investors watch iTeos' (ITOS) conference presentations?
